Sign up Australia
Proactive Investors - Run By Investors For Investors

The Hydroponics Company details domestic medicinal cannabis production

Canndeo is building a domestic medicinal cannabis production and supply capability.
The Hydroponics Company details domestic medicinal cannabis production
Canndeo has received a cannabis research licence

The Hydroponics Company (ASX:THC) through its wholly-owned medicinal cannabis subsidiary, Canndeo Limited, is building a domestic medicinal cannabis production and supply capability.

This is being achieved through the licensing program established under the Narcotic Drugs Act 1967.

There are three relevant licences issued by the Office of Drug Control:

- A cannabis research licence allows the production of cannabis strains for research into medicinal use;

- A medicinal cannabis licence allows either cultivation or production or both of medicinal cannabis plants; and

- A manufacturing licence allows the manufacture of cannabis and cannabis extract into medicinal cannabis.

Canndeo received a cannabis research licence on 6 July 2017, and its application for a medicinal cannabis licence is progressing in its assessment and a manufacturing licence application is currently under development.

THC said that it will advise the market when the licences are granted and also with regard its domestic medicinal cannabis production and supply capability.

View full THC profile View Profile

The Hydroponics Company Timeline

Related Articles

man on a ventilator
January 25 2018
The share price, 280p a year ago, has tracked the progress the firm has made in the clinic with its lead product Traumakine
Woman stroking face
October 03 2017
Its SkinBiotix cream was assessed for cellular toxicity
scientist looking through a microscope
November 01 2017
As of March, ReNeuron had £53mln in cash equivalents but its market value is not too much above that....

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use